a, Consensus clustering of 534 GBM on the activity of
192 survival-associated pathways (p < 0.05, log-rank
test; p-value of individual pathways are reported in Supplementary Table
6b). Columns and rows are individual tumors. Left track: red,
GPM; green, MTC; blue, NEU; cyan, PPR; black, unclassified. b,
Heatmap of pathway activity in 304 classified GBM including 126 out of 192
survival-associated and differentially active pathways in the four GBM
subtypes (effect size > 0.3 and FDR < 0.01, two-sided MWW
test). Columns are individual tumors and rows are pathway activity. Pathways
characteristically activated in each core subtype are indicated. Left and
top tracks: red, GPM; green, MTC; blue, NEU; cyan, PPR. c,
Heatmap of genes differentially expressed and upregulated in GBM subtypes
(n = 304 tumors; Kruskal-Wallis analysis with post hoc
correction by Nemenyi’s test for multiple comparison; FDR <
0.01 and log2(FC) > 0.5). Columns are individual tumors,
rows are genes. Representative genes specifically upregulated in each GBM
subtype are indicated. Tracks are as in b. d, Rank order plot
of changes of genes expressed in GBM NEU. Genes are ranked from left to
right in increasing expression order. Red dots indicate neurotransmitter
receptors differentially expressed in NEU tumors and cells
(n = 2,799 cells for dataset 1, n =
9,652 cells for dataset 2, n = 4,916 cells for dataset 3,
n = 304 tumors for TCGA dataset; log2(FC)
> 0.3, FDR < 0.05, two-sided MWW test). For each dataset,
upregulated genes in neurotransmitter receptor families are indicated by
colors. e, Rank order plot of changes of genes expressed in GBM
PPR. Genes are ranked as in d. Red dots indicate neural progenitor genes
differentially expressed in each dataset (n = 2,799 cells
for dataset 1, n = 9,652 cells for dataset 2,
n = 4,916 cells for dataset 3, n = 304
tumors for TCGA dataset; log2(FC) > 0.3, FDR <
0.05, two-sided MWW test). Representative genes differentially expressed in
at least three datasets are indicated. f, Heatmap showing the
50 highest scoring genes of the four GBM subtypes-specific signatures. Rows
are genes and columns are tumors (n = 304 tumors). Track
are as in b, c. g, Two-dimensional representation of GBM
subtype enrichment scores (n = 304 tumors). Quadrant are
GBM subtypes, the position of dots (tumors) reflects the relative
subtype-specific score of each tumor as indicated by x- and y-axes, and
their color the subtype simplicity score. Gray, tumors that do not fall in
the respective subtype quadrant.